The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

Shares in Novavax (NASDAQ:NVAX) slumped in premarket US trading on Wednesday after the US Food and Drug Administration placed a trial of its experimental COVID-19 and influenza vaccine combination on ...

COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased ...

(Reuters) - The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on ...

Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

The most important thing to know is that the COVID vaccine is safe and effective, says Dr. Watkins. With that said, side effects from the COVID vaccine are rare, says Dr. Cennimo, and they usually ...

Following hurricane damage that shuttered a North Carolina plant that makes 60% of the country's IV fluids, U.S. he ...

Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

Ernie Hudson is tempting his fans with a sexy new partnership.   The “Ghostbusters” actor is joining forces with ...

Recent developments in the health sector highlight increased cancer drug sales for Johnson & Johnson, Bayer's new menopause drug application, FDA approvals for surgical devices, and strategic moves by ...